Raymond Bunch

LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO.

Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA.

HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts.

Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

HealthCare Ventures VII LP seeks investment opportunities in life science companies located in the US with an annual revenues ranging from $50 - $100 million. The fund targets companies operating in the fields of cancer therapy, infectious diseases, cardiovascular diseases, central nervous system disorders, immunotherapy, novel manufacturing technologies and novel lab scale instruments & reagents. It provides financing in the form of equity and debt convertible to equity for early and later stage capital requirements with an investment size of $1,000,000 - $20,000,000. It also makes investments in both private and public companies.

Part of Baxter International, Inc., Baxter Biotech Group manufactures medical devices. The company is based in Tokyo, Japan.

Part of Deloitte LLP (New York), Deloitte & Touche, Inc. provides accounting services. The company is based in Calgary, Canada.

Dominus Capital LP (Dominus Capital) is a private equity firm founded in 2008 by Gary A. Binning, Robert D. Haswell and Ashish B. Rughwani. The firm is headquartered in New York.

BluSky Restoration Contractors LLC engages in contracting and restoration services. It provides commercial, industrial, governmental and multifamily restoration, renovation, environmental and roofing services. The company was founded by Terry L. Shadwick and Andrew J. Bakker in 2004 and is headquartered in Centennial, CO.

Alliances Management, Inc. is a strategic consulting firm that delivers project management, operations, and administrative services. The company was founded on and is headquartered in Redwood City, CA.

Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia.

Part of HealthCare Ventures LLC, Healthcare Strategic Partners, LLC is an American company that provides healthcare services.

Cerebral Therapeutics, Inc. develops neurological therapeutics for uncontrolled neurological diseases. It is a clinical-stage company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy. The firm offers long-term implanted drug-device combination therapies that bypass the blood-brain barrier to deliver optimal doses of specially formulated neurological therapeutics directly into the target region of the brain. The company was founded by Daniel J. Abrams and James P. Kelleher and is headquartered in Aurora, CO.